Quantum BioPharma Ltd. (QNTM) — Financial Flexibility Index
Quantum BioPharma Ltd. (QNTM) has a Financial Flexibility Index of -0.26x as of September 2025. Free cash flow of $-1.72 Million (operating CF $-1.72 Million minus capex $0.00) represents 0% of total liabilities ($6.65 Million). Check QNTM strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Quantum BioPharma Ltd. Financial Flexibility Index (2015–2024)
Historical Financial Flexibility Index trend for Quantum BioPharma Ltd. across 10 annual periods. See QNTM working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Quantum BioPharma Ltd. (2015–2024)
Year-by-year free cash flow to debt coverage for Quantum BioPharma Ltd.. For the full company profile including market capitalisation, see QNTM market cap overview.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.03x | $-6.88 Million | $-6.88 Million | $6.68 Million | ▲ +56.6% |
| 2023 | -2.37x | $-10.83 Million | $-10.83 Million | $4.57 Million | ▲ +33.3% |
| 2022 | -3.55x | $-27.97 Million | $-28.33 Million | $7.87 Million | ▼ -55.1% |
| 2021 | -2.29x | $-20.25 Million | $-20.75 Million | $8.83 Million | ▲ +32.2% |
| 2020 | -3.38x | $-19.13 Million | $-19.13 Million | $5.66 Million | ▼ -74.8% |
| 2019 | -1.93x | $-13.42 Million | $-13.71 Million | $6.94 Million | ▲ +76.7% |
| 2018 | -8.29x | $-10.61 Million | $-13.58 Million | $1.28 Million | ▼ -239.9% |
| 2017 | 5.93x | $5.97 Million | $-119.18K | $1.01 Million | ▲ +1436.8% |
| 2016 | -0.44x | $-27.24K | $-27.24K | $61.43K | ▼ -42203.9% |
| 2015 | 0.00x | $-63.44 | $-63.44 | $60.53K | — |